Справка
x
Поиск
Закладки
Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Плоскоклеточный рак анального канала, анального края, перианальной кожи
Список литературы
Поставить закладку
Glynne-Jones, R., et al.,
Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.
Eur J Surg Oncol, 2014.
40
(10): p. 1165-76.
Hoots, B.E., et al.,
Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions.
Int J Cancer, 2009.
124
(10): p. 2375-83.
Laghi, A., et al.,
Magnetic Resonance Imaging of the anal canal using high resolution sequences and phased array coil: visualization of anal sphincter complex.
La Radiologia medica, 2002.
103
(4): p. 353-359.
Stoker, J., et al.,
Imaging of anorectal disease.
British journal of surgery, 2000.
87
(1): p. 10-27.
Goh, V., et al.,
Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome?
International Journal of Radiation Oncology* Biology* Physics, 2010.
78
(3): p. 715-721.
Kachnic, L.A., et al.,
RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal.
Int J Radiat Oncol Biol Phys, 2013.
86
(1): p. 27-33.
Bazan, J.G., et al.,
Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal.
Cancer, 2011.
117
(15): p. 3342-51.
Dewas, C.V., et al.,
Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
Radiat Oncol, 2012.
7
: p. 201.
Ortholan, C., et al.,
Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study).
Int J Radiat Oncol Biol Phys, 2012.
82
(5): p. 1988-95.
Matthews, J.H., et al.,
T1-2 anal carcinoma requires elective inguinal radiation treatment--the results of Trans Tasman Radiation Oncology Group study TROG 99.02.
Radiother Oncol, 2011.
98
(1): p. 93-8.
Zilli, T., et al.,
Elective inguinal node irradiation in early-stage T2N0 anal cancer: prognostic impact on locoregional control.
Int J Radiat Oncol Biol Phys, 2013.
87
(1): p. 60-6.
Janssen, S., et al.,
Anal cancer treated with radio-chemotherapy: correlation between length of treatment interruption and outcome.
Int J Colorectal Dis, 2009.
24
(12): p. 1421-8.
Meyer, A., et al.,
Chemoradiotherapy in patients with anal cancer: impact of length of unplanned treatment interruption on outcome.
Acta Oncol, 2006.
45
(6): p. 728-35.
Konski, A., et al.,
Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08.
Int J Radiat Oncol Biol Phys, 2008.
72
(1): p. 114-8.
Gunderson, L.L., et al.,
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
J Clin Oncol, 2012.
30
(35): p. 4344-51.
James, R.D., et al.,
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 x 2 factorial trial.
Lancet Oncol, 2013.
14
(6): p. 516-24.
Faivre, C., et al.,
[5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer].
Bulletin du cancer, 1999.
86
(10): p. 861-865.
Mullen, J.T., et al.,
Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal.
Ann Surg Oncol, 2007.
14
(2): p. 478-83.
Cummings, B.J., et al.,
Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C.
Int J Radiat Oncol Biol Phys, 1991.
21
(5): p. 1115-25.
Schlienger, M., et al.,
Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases.
Int J Radiat Oncol Biol Phys, 1989.
17
(6): p. 1141- 51.
Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. European Journal of Surgical Oncology. 2014 Oct 1;40(10):1165-76.
Mendenhall, W.M., et al.,
Squamous cell carcinoma of the anal margin.
Oncology (Williston Park), 1996.
10
(12): p. 1843-8; discussion 1848, 1853-4.
Newlin, H.E., et al.,
Squamous cell carcinoma of the anal margin.
J Surg Oncol, 2004.
86
(2): p. 55-62; discussion 63.
Для продолжения работы требуется
Registration
Предыдущая страница
Следующая страница
Table of contents
Ключевые слова
Список сокращений
1. Краткая информация
+
2. Диагностика
+
3. Лечение
+
4 Реабилитация
5. Профилактика
6. Дополнительная информация, влияющая на течение и исход заболевания
Критерии оценки качества медицинской помощи
Список литературы
Приложение А1. Состав рабочей группы
Приложение А2. Методология разработки клинических рекомендаций
Приложение Б. Алгоритмы ведения пациента
Приложение В. Информация для пациентов
Данный блок поддерживает скрол*